Package Leaflet: Information for the Patient
Cefuroxima Aristo 250 mg Film-Coated Tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Package Leaflet
Cefuroxima Aristo contains cefuroxime as the active substance. It is an antibiotic used in both adults and children. It works by killing the bacteria that cause infections. It belongs to a group of medicines called cephalosporins.
Antibiotics are used to treat bacterial infections and are not effective against viral infections such as the flu or the common cold. It is important that you follow the instructions regarding dose, administration, and duration of treatment indicated by your doctor. Do not store or reuse this medication. If you have any leftover antibiotic after completing treatment, return it to the pharmacy for proper disposal. Do not throw medicines down the drain or into the trash. |
Cefuroxime is used to treat infections of:
Cefuroxime can also be used to:
Your doctor may analyze the type of bacteria causing your infection and check if the bacteria are sensitive to cefuroxime during treatment.
Do not take cefuroxime
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medicine.
Severe skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported with cefuroxime treatment. Seek medical attention immediately if you notice any of the symptoms related to these severe skin reactions described in section 4.
Children
Cefuroxime is not recommended for children under 3 months, as safety and efficacy for this age group are unknown.
You should be aware of certain symptoms such as allergic reactions, fungal infections (such as Candida), and severe diarrhea (pseudomembranous colitis) while taking cefuroxime. This will reduce the risk of possible complications. See "Symptoms to be aware of" in section 4.
If you need a blood test
Cefuroxime may affect the results of blood sugar tests or the Coombs test. If you need a blood test:
Other medicines and cefuroxime
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Medicines used to reduce stomach acidity (e.g., antacidsfor heartburn) may affect the action of this medicine.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Do not take this medicine during pregnancy and breastfeeding unless your doctor has told you to do so.
If you are breastfeeding and have digestive problems (diarrhea, fungal infections) or spots, stop breastfeeding and consult your doctor immediately.
Driving and using machines
Cefuroxime may cause dizziness and other side effects that may affect your ability to be alert.
This medicine contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per film-coated tablet; this is essentially "sodium-free".
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.
The recommended dose is
Adults
The recommended dose of cefuroxime is 250 mg to 500 mg twice a day, depending on the severity and type of infection.
Children
The recommended dose of cefuroxime is 10 mg/kg (up to a maximum of 125 mg) to 15 mg/kg (up to a maximum of 250 mg) twice a day, depending on:
Cefuroxime is not recommended in children under 3 months, as safety and efficacy for this age group are unknown.
Depending on the disease and how you or your child responds to treatment, the initial dose may be adjusted or it may be necessary to administer more than one treatment cycle.
Patients with kidney problems
If you have kidney problems, your doctor may change your dose.
Method of administration
Oral use.
Take this medicine after meals. This will help the treatment to be more effective. Swallow the cefuroxime tablets whole with water.
The tablets can be divided into equal doses.
Do not chew or crush the tablets.
If you take more cefuroxime than you should
If you take too much cefuroxime, you may experience neurological disorders, in particular, you may have a higher risk of having epileptic seizures (convulsions).
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take cefuroxime
Do not take a double dose to make up for forgotten doses. Simply continue with the next dose as usual.
If you stop taking cefuroxime
Do not stop taking cefuroxime without prior advice.
It is important that you complete the entire treatment with cefuroxime. Do not stop it unless your doctor tells you to do so, even if you have started to feel better. If you do not complete the treatment cycle, the infection may recur.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Symptoms to be aware of
A small number of people who took cefuroxime experienced an allergic reaction or a potentially severe skin reaction. The symptoms of these reactions include:
Other symptoms to be aware of while taking cefuroxime:
Common side effects
May affect up to 1 in 10 people:
Common side effects that may appear in blood tests:
Uncommon side effects
May affect up to 1 in 100 people:
Uncommon side effects that may appear in blood tests:
Other side effects
Other side effects have occurred in a very small number of people, but their exact frequency is unknown:
Side effects that may appear in blood tests:
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after "EXP". The expiry date refers to the last day of the month shown.
Do not store above 25°C.
Keep the original packaging to protect from light.
Do not take this medicine if the tablets are cracked or show other visible signs of deterioration.
Medicines should not be disposed of via wastewater or household waste. Return the containers and any unused medicines to the pharmacy. If you are unsure, ask your pharmacist how to dispose of containers and unused medicines. This will help protect the environment.
Composition of Cefuroxima Aristo
Each film-coated tablet contains 250 mg of cefuroxime (as cefuroxime axetil).
Core of the tablet: Microcrystalline cellulose, sodium lauryl sulfate, sodium croscarmellose, anhydrous colloidal silica, magnesium stearate.
Coating material: Hypromellose, titanium dioxide (E 171), hydroxypropylcellulose, microcrystalline cellulose, stearic acid.
Appearance of the product and packaging contents
Film-coated tablets, white to off-white, round, biconvex, with a diameter of 11 mm and a score line.
PVC/PVdC-aluminum blisters.
Package sizes: 10, 12, 14, 16, 20, and 24 film-coated tablets. The tablet can be divided into equal doses.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Aristo Pharma GmbH
Wallenroder Straße 8-10
13435 Berlin
Germany
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Aristo Pharma Iberia, S.L.
C/ Solana, 26
28850, Torrejón de Ardoz
Madrid, Spain
This medicine is authorized in the Member States of the European Economic Area under the following names:
Austria Cefuroxim Aristo 250 mg Filmtabletten
Germany Cefurax 250 mg Filmtabletten
Portugal Cefuroxima Aristo 250 mg film-coated tablets
Spain Cefuroxima Aristo 250 mg film-coated tablets EFG
Date of last revision of this leaflet: May 2024
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/